EPCAM and cancer: Patient, 1001 and, 1002 experienced decrease of ascites generation and reduction of EpCAM-positive cancer cells in ascites samples. Patient, 1003 experienced rapid tumor shrinkage in the liver area observed by ultrasound imaging and PET-CT